SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

H.C. Wainwright Maintains Buy on ASLAN Pharmaceuticals, Lowers Price Target to $2

H.C. Wainwright maintains ASLAN Pharmaceuticals (NASDAQ:ASLN) with a Buy and lowers the price target from $9 to $2.

Benzinga · -

H.C. Wainwright maintains ASLAN Pharmaceuticals (NASDAQ:ASLN) with a Buy and lowers the price target from $9 to $2.